OOIR: Observatory of International Research

Papers

(The TQCC of Applied Health Economics and Health Policy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review	139
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil	72
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities	40
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework	38
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–2020	33
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context	32
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China	30
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach	27
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study	27
Population Norms for SF-6Dv2 and EQ-5D-5L in China	23
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	23
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines	22
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand	22
The Effect of Price Changes and Teaspoon Labelling on Intention to Purchase Sugar-Sweetened Beverages: A Discrete Choice Experiment	21
The Economics of Antibiotic Resistance: A Systematic Review and Meta-analysis Based on Global Research	21
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom	21
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis	20
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions	19
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches	19
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?	19
The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates	18
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis	17
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana	16
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?	16
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective	15

Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	14
How is Value Defined in Molecular Testing in Cancer? A Scoping Review	14
Including Pharmaceuticals in Bundled Payments	14
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies	14
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China	13
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients	12
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts	12
Social Costs of Smoking in the Czech Republic	12
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach	12
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes	11
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon	11
Contextual Factors that Influence Antibiotic Prescribing: A Discrete Choice Experiment of GP Registrars	11
Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers	10
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making	10
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India	10
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study	10
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	10
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?	10
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040	9
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy	9
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models	9
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries	9
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia	9
Trump’s Drug Pricing Order and the Domestic Economic Trade-Off	9
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi	9
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	9
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment	9
Young People’s Preferences for Web-Based Mental Health Interventions for Managing Anxiety and Depression: A Discrete Choice Experiment	8
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective	8
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis	8
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland	8
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges	8
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study	8
Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review	8
Effect of Competition on Generic Drug Prices	8
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance	8
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature	7
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting	7
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold	7
A Systematic Review of Economic Evaluations on Interventions Targeting Insomnia or Hypersomnia	7
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value	7
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis	7
Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia	7
Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children	7
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older	7
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework	7
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians	7
Forecasting the Incremental Value to Society Created by a Class of New Prescription Drugs: A Proposed Methodology and Its Application to Treating Chronic Hepatitis C in India	7
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review	7
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework	6

Headroom Analysis for Early Economic Evaluation: A Systematic Review	6
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment	6
EQ-5D-5L Population Norms for Italy	6
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review	6
Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer	6
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets	6
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment	6